Carly Whyte is an early-career researcher with expertise in the cellular and molecular mechanisms underlying immune-mediated pathology. Her research focuses on understanding how our immune systems can recognise and respond to cancer, with a view towards developing new immunotherapies for patients with solid tumours. She is supported by a Passe and Williams Junior Fellowship.
Dr Whyte holds a PhD in Immunology from the University of Adelaide, during which she discovered a previously unknown regulator of immune cell migration into tumours called ACKR4. She was then appointed as a postdoctoral research scientist at the Babraham Institute, Cambridge, UK and a Research Associate at Fitzwilliam College, University of Cambridge. During this... Read more
About me
Carly Whyte is an early-career researcher with expertise in the cellular and molecular mechanisms underlying immune-mediated pathology. Her research focuses on understanding how our immune systems can recognise and respond to cancer, with a view towards developing new immunotherapies for patients with solid tumours. She is supported by a Passe and Williams Junior Fellowship.
Dr Whyte holds a PhD in Immunology from the University of Adelaide, during which she discovered a previously unknown regulator of immune cell migration into tumours called ACKR4. She was then appointed as a postdoctoral research scientist at the Babraham Institute, Cambridge, UK and a Research Associate at Fitzwilliam College, University of Cambridge. During this postdoctoral training with Prof. Adrian Liston, Dr Whyte elucidated signaling networks of the cytokine IL-2, discovering novel mechanisms of action for this protein and identifying new regulatory networks which explained some of the common side-effects of therapeutic use of IL-2.
About me
Doctor of Philosophy University of Adelaide
Bachelor of Science (Honours) University of Adelaide
Bachelor of Science (Biomedical Science) University of Adelaide
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2023 |
Open access
2
89
|
2022 |
Open access
12
78
|
2022 |
Open access
5
186
|
2022 |
Open access
57
282
|
2021 |
Open access
21
44
|
2021 |
Open access
21
34
|
2020 |
Open access
33
205
|
2020 |
Open access
169
296
|
2020 |
Open access
23
14
17
|
2019 |
Open access
63
24
|
2018 |
Open access
17
16
13
|
2017 |
Open access
24
23
1
|
2017 |
Open access
90
74
15
|
2015 |
Open access
101
94
92
|
External engagement & recognition
Organisation | Country |
---|---|
Australian National University | AUSTRALIA |
Babraham Institute | UNITED KINGDOM |
Benaroya Research Institute | UNITED STATES |
Catholic University of Leuven | BELGIUM |
FlowJo (United States) | UNITED STATES |
Free University of Amsterdam | NETHERLANDS |
Ku Leuven | BELGIUM |
Monash University | AUSTRALIA |
QIMR Berghofer Medical Research Institute | AUSTRALIA |
University Hospital Regensburg | GERMANY |
University of Adelaide | AUSTRALIA |
University of Cambridge | UNITED KINGDOM |
University of Melbourne | AUSTRALIA |
University of Queensland | AUSTRALIA |
University of Rochester Medical Center | UNITED STATES |
University of South Australia | AUSTRALIA |
University of Washington | UNITED STATES |
VIB Bioinformatics Core | BELGIUM |
VIB-KU Leuven Center for Brain & Disease Research | BELGIUM |
Walter and Eliza Hall Institute of Medical Research | AUSTRALIA |
Wellcome Sanger Institute | UNITED KINGDOM |